Literature DB >> 19242319

Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury.

Benjamin T Suratt1, Mark D Eisner, Carolyn S Calfee, Jenna B Allard, Laurie A Whittaker, Dustin T Engelken, Joseph M Petty, Thomas Trimarchi, Lauren Gauthier, Polly E Parsons.   

Abstract

OBJECTIVES: To evaluate the association between plasma granulocyte colony-stimulating factor (G-CSF) levels and clinical outcomes including mortality in patients with acute lung injury (ALI), and to determine whether lower tidal volume ventilation was associated with a more rapid decrease in plasma G-CSF over time in patients with ALI.
DESIGN: Retrospective measurement of G-CSF levels in plasma samples that were collected prospectively as part of a large multicenter clinical trial.
SETTING: Intensive care units in ten university centers. PATIENTS: The study included 645 patients enrolled in the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Network trial of lower tidal volumes compared with traditional tidal volumes for ALI.
MEASUREMENTS AND MAIN RESULTS: Baseline plasma levels of G-CSF were associated with an increased risk of death and a decrease in ventilator-free days and organ failure-free days in multivariate analyses controlling for ventilation strategy, age, and sex (Odds ratio death 1.2/log10 increment G-CSF, 95% confidence interval 1.01 to 1.4). Stratification of G-CSF levels into quartiles revealed a strong association between the highest levels of G-CSF and an increased risk of death and decreased ventilator-free days and organ failure-free days in multivariate analyses controlling for ventilation strategy, Acute Physiology and Chronic Health Evaluation III score, Pao2/Fio2 ratio, creatinine, and platelet count (p < 0.05). Subgroup multivariate analysis of patients with sepsis as their risk factor for ALI revealed a U-shaped association between mortality and G-CSF levels such that risk increased linearly from the second through fourth (highest) quartiles, yet also increased in the first (lowest) quartile. G-CSF levels decreased over time in both tidal volume groups, and there was no statistical difference in the extent of decrease between ventilator strategies.
CONCLUSIONS: In patients with ALI, plasma G-CSF levels are associated with morbidity and mortality, but these levels are not influenced by tidal volume strategy. In patients with sepsis-related ALI, a bimodal association between baseline plasma G-CSF levels and subsequent morbidity and mortality from this disease was found.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242319      PMCID: PMC2827851          DOI: 10.1097/CCM.0b013e31819c14fa

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  55 in total

1.  Granulocyte colony-stimulating factor or neutrophil-induced pulmonary toxicity: myth or reality? Systematic review of clinical case reports and experimental data.

Authors:  E Azoulay; H Attalah; A Harf; B Schlemmer; C Delclaux
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

2.  Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study.

Authors:  V Pettilä; O Takkunen; T Varpula; A Markkola; K Porkka; V Valtonen
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

3.  Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome.

Authors: 
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

4.  G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome.

Authors:  A Aggarwal; C S Baker; T W Evans; P L Haslam
Journal:  Eur Respir J       Date:  2000-05       Impact factor: 16.671

5.  Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome.

Authors:  M D Eisner; T Thompson; L D Hudson; J M Luce; D Hayden; D Schoenfeld; M A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2001-07-15       Impact factor: 21.405

6.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.

Authors:  Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

7.  Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome.

Authors:  G Matute-Bello; W C Liles; F Radella; K P Steinberg; J T Ruzinski; L D Hudson; T R Martin
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

8.  Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. The ARDS Network.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

9.  Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.

Authors:  J J Presneill; P M Waring; J E Layton; D W Maher; J Cebon; N S Harley; J W Wilson; J F Cade
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

10.  Filgrastim in patients with pneumonia and severe sepsis or septic shock.

Authors:  R Wunderink; K Leeper; R Schein; S Nelson; B DeBoisblanc; N Fotheringham; E Logan
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

View more
  12 in total

1.  Bronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients.

Authors:  Renee D Stapleton; Benjamin T Suratt; Margaret J Neff; Mark M Wurfel; Lorraine B Ware; John T Ruzinski; Ellen Caldwell; Teal S Hallstrand; Polly E Parsons
Journal:  Biomarkers       Date:  2019-03-04       Impact factor: 2.658

2.  The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Stanley M Berry; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2011-07-30       Impact factor: 1.901

3.  Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis.

Authors:  Daniel Kreisel; Seiichiro Sugimoto; Jeremy Tietjens; Jihong Zhu; Sumiharu Yamamoto; Alexander S Krupnick; Ruaidhri J Carmody; Andrew E Gelman
Journal:  J Clin Invest       Date:  2010-12-13       Impact factor: 14.808

4.  Myeloperoxidase-derived 2-chlorofatty acids contribute to human sepsis mortality via acute respiratory distress syndrome.

Authors:  Nuala J Meyer; John P Reilly; Rui Feng; Jason D Christie; Stanley L Hazen; Carolyn J Albert; Jacob D Franke; Celine L Hartman; Jane McHowat; David A Ford
Journal:  JCI Insight       Date:  2017-12-07

5.  Therapeutic exercise attenuates neutrophilic lung injury and skeletal muscle wasting.

Authors:  D Clark Files; Chun Liu; Andrea Pereyra; Zhong-Min Wang; Neil R Aggarwal; Franco R D'Alessio; Brian T Garibaldi; Jason R Mock; Benjamin D Singer; Xin Feng; Raghunatha R Yammani; Tan Zhang; Amy L Lee; Sydney Philpott; Stephanie Lussier; Lina Purcell; Jeff Chou; Michael Seeds; Landon S King; Peter E Morris; Osvaldo Delbono
Journal:  Sci Transl Med       Date:  2015-03-11       Impact factor: 17.956

6.  Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors.

Authors:  Maneesh Bhargava; Trisha L Becker; Kevin J Viken; Pratik D Jagtap; Sanjoy Dey; Michael S Steinbach; Baolin Wu; Vipin Kumar; Peter B Bitterman; David H Ingbar; Christine H Wendt
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

7.  Analysis of mechanical ventilation and lipopolysaccharide‑induced acute lung injury using DNA microarray analysis.

Authors:  Yuqing Chen; Xin Zhou; Ling Rong
Journal:  Mol Med Rep       Date:  2015-02-11       Impact factor: 2.952

8.  The innate immune response in HIV/AIDS septic shock patients: a comparative study.

Authors:  Rodrigo T Amancio; Andre M Japiassu; Rachel N Gomes; Emersom C Mesquita; Edson F Assis; Denise M Medeiros; Beatriz Grinsztejn; Patrícia T Bozza; Hugo C Castro-Faria Neto; Fernando A Bozza
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

9.  Tristetraprolin Overexpression in Non-hematopoietic Cells Protects Against Acute Lung Injury in Mice.

Authors:  Ishita Choudhary; Thao Vo; Chandra S Bathula; Richa Lamichhane; Brandon W Lewis; Jayme Looper; Samithamby Jeyaseelan; Perry J Blackshear; Yogesh Saini; Sonika Patial
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

10.  Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model.

Authors:  Jessica Morales-Ortíz; Victoria Deal; Fiorella Reyes; Gerónimo Maldonado-Martínez; Nahomy Ledesma; Franklin Staback; Cheyanne Croft; Amanda Pacheco; Humberto Ortiz-Zuazaga; C Christian Yost; Jesse W Rowley; Bismark Madera; Alex St John; Junmei Chen; Jose Lopez; Matthew T Rondina; Robert Hunter; Angelia Gibson; A Valance Washington
Journal:  Blood       Date:  2018-10-03       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.